Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score

In addition to thromboembolism, atrial fibrillation (AF) may also predispose to major adverse cardiovascular events (MACE) attributable to coronary artery disease (CAD), including myocardial infarction (MI). The 2MACE score (2 points - Metabolic syndrome and Age≥75years, 1 point - MI/revascularizati...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cardiology 2017-12, Vol.249, p.191-197
Main Authors: Polovina, Marija, Đikić, Dijana, Vlajković, Ana, Vilotijević, Matej, Milinković, Ivan, Ašanin, Milika, Ostojić, Miodrag, Coats, Andrew J.S., Seferović, Petar M.
Format: Article
Language:English
Subjects:
Aged
Atrial fibrillation
Atrial Fibrillation - diagnostic imaging
Atrial Fibrillation - mortality
Atrial Fibrillation - physiopathology
Cardiac death
Cardiovascular Diseases - diagnostic imaging
Cardiovascular Diseases - mortality
Cardiovascular Diseases - physiopathology
Cohort Studies
Death
Electrocardiography - mortality
Electrocardiography - standards
Electrocardiography - trends
Female
Follow-Up Studies
Humans
Major adverse cardiovascular event
Male
Metabolic syndrome
Middle Aged
Myocardial infarction
Risk Factors
Risk score
Severity of Illness Index
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In addition to thromboembolism, atrial fibrillation (AF) may also predispose to major adverse cardiovascular events (MACE) attributable to coronary artery disease (CAD), including myocardial infarction (MI). The 2MACE score (2 points - Metabolic syndrome and Age≥75years, 1 point - MI/revascularization, Congestive heart failure/ejection-fraction
ISSN:0167-5273
1874-1754
DOI:10.1016/j.ijcard.2017.09.154